Deoxybouvardin-glucoside induces apoptosis in non-small cell lung cancer cells by targeting EGFR/MET and AKT signaling pathway
Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related deaths worldwide. Its treatment is complicated due to the development of resistance to conventional chemotherapy and targeted therapy. Deoxybouvardin and related cyclic hexapeptides reportedly exhibit antitumor activities, but t...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund
2024-10-01
|
Series: | EXCLI Journal : Experimental and Clinical Sciences |
Subjects: | |
Online Access: | https://www.excli.de/excli/article/view/7359 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|